- Home
- LSTA vs COCH Comparison
LSTA vs COCH Comparison
Compare LSTA & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSTA
- COCH
- Stock Information
- Founded
- LSTA 1980
- COCH 1995
- Country
- LSTA United States
- COCH United States
- Employees
- LSTA N/A
- COCH N/A
- Industry
- LSTA Misc Health and Biotechnology Services
- COCH Blank Checks
- Sector
- LSTA Health Care
- COCH Finance
- Exchange
- LSTA Nasdaq
- COCH Nasdaq
- Market Cap
- LSTA 22.5M
- COCH 31.6M
- IPO Year
- LSTA N/A
- COCH N/A
- Fundamental
- Price
- LSTA $2.70
- COCH $1.64
- Analyst Decision
- LSTA Strong Buy
- COCH Strong Buy
- Analyst Count
- LSTA 2
- COCH 2
- Target Price
- LSTA $23.50
- COCH $9.25
- AVG Volume (30 Days)
- LSTA 26.6K
- COCH 26.4K
- Earning Date
- LSTA 08-11-2025
- COCH 08-11-2025
- Dividend Yield
- LSTA N/A
- COCH N/A
- EPS Growth
- LSTA N/A
- COCH N/A
- EPS
- LSTA N/A
- COCH N/A
- Revenue
- LSTA $1,000,000.00
- COCH $212,000.00
- Revenue This Year
- LSTA N/A
- COCH $5.93
- Revenue Next Year
- LSTA N/A
- COCH $17.69
- P/E Ratio
- LSTA N/A
- COCH N/A
- Revenue Growth
- LSTA N/A
- COCH N/A
- 52 Week Low
- LSTA $1.87
- COCH $1.21
- 52 Week High
- LSTA $4.20
- COCH $3.99
- Technical
- Relative Strength Index (RSI)
- LSTA 51.78
- COCH 60.61
- Support Level
- LSTA $2.55
- COCH $1.43
- Resistance Level
- LSTA $3.09
- COCH $1.59
- Average True Range (ATR)
- LSTA 0.28
- COCH 0.11
- MACD
- LSTA -0.01
- COCH 0.02
- Stochastic Oscillator
- LSTA 48.00
- COCH 82.76
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.